Roy Papatheodorou

In-House Counsel at Novartis AG

Roy Papatheodorou

Roy Papatheodorou

In-House Counsel at Novartis AG

Biography

Mr. Roy Papatheodorou is Executive Vice President & General Counsel at Actavis Group hf.Mr. Papatheodorou was previously employed as a Principal by Linklaters.He received his undergraduate degree from King's College London.

Overview
Career Highlights

Actavis Group hf

RelSci Relationships

446

Relationships
RelSci Relationships are individuals Roy Papatheodorou likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Hogan & Lovells LLP

Relationship likelihood: Strong

Partner Norton Rose Fulbright US LLP at Norton Rose Fulbright

Relationship likelihood: Strong

Counsel at Kaye Scholer LLP

Relationship likelihood: Strong

Kaye Scholer LLP

Relationship likelihood: Strong

Partner at Kirkland & Ellis LLP

Relationship likelihood: Strong

Partner at Hogan & Lovells LLP

Relationship likelihood: Strong

Partner at Linklaters LLP

Relationship likelihood: Strong

Associate at Hogan & Lovells LLP

Relationship likelihood: Strong

Managing Partner at Freshfields Bruckhaus Deringer LLP

Relationship likelihood: Strong

Partner at Freshfields Bruckhaus Deringer LLP

Relationship likelihood: Strong

Paths to Roy Papatheodorou
Potential Connections via
Relationship Science
You
Roy Papatheodorou
In-House Counsel at Novartis AG
Education
Undergraduate Degree

King's College London was founded by King George IV and the Duke of Wellington (then Prime Minister) in 1829 as a university college in the tradition of the Church of England. It now welcomes staff and students of all faiths and beliefs.

Career History
In-House Counsel
Current

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Executive Vice President & General Counsel
2011 - Prior

Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland.

Professional
Prior

Linklaters LLP is a multinational law firm headquartered in London, United Kingdom. It was founded in 1838 and is a member of the Magic Circle of leading British law firms. It currently employs around 2,600 lawyers and has 29 offices across 20 countries.

Transactions
Details Hidden

GlaxoSmithKline Plc purchases Novartis AG /Human Vaccines Operations from Novartis AG

Details Hidden

Eli Lilly & Company purchases Novartis Animal Health, Inc. from Novartis AG

Other Affiliations

Roy Papatheodorou is affiliated with Novartis AG, Actavis Group hf, Linklaters LLP

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Roy Papatheodorou. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Roy Papatheodorou's profile does not indicate a business or promotional relationship of any kind between RelSci and Roy Papatheodorou.